Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Pulmonary and Respiratory Medicine journal rankings 2024
364 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 364 ranked journals in 2024. The median journal has an OJR of 0.64, below the world average of 1.00, down 0.04 on 2023; Q1 starts at OJR 1.02. The top three are Drugs, The Lancet Respiratory Medicine, and NEJM Evidence.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
364 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1DrugsAdis, Springer Healthcare · New Zealand | 5.24Q1 | 15.66 1.06 up from 2023 | 432 | 60% | $5,990 | ||
2The Lancet Respiratory MedicineElsevier BV · Netherlands | 4.83Q1 | 14.04 3.74 down from 2023 | 622 | 36% | $7,280 | ||
3NEJM EvidenceUnited States | 4.42Q1 | 11.19 0.32 down from 2023 | 294 | 23% | — | ||
4European UrologyElsevier BV · Switzerland | 4.40Q1 | 13.40 2.98 up from 2023 | 650 | 14% | $5,250 | ||
5European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 3.21Q1 | 12.22 1.47 up from 2023 | 299 | 100% | — | ||
6Intensive Care MedicineSpringer Science+Business Media · Germany | 3.15Q1 | 6.75 3.35 down from 2023 | 802 | 57% | $5,190 | ||
7Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 2.90Q1 | 7.27 0.15 up from 2023 | 1,913 | 99% | $5,100 | ||
8European Respiratory JournalEuropean Respiratory Society | 2.87Q1 | 8.89 0.23 up from 2023 | 1,124 | 53% | — | ||
9Journal of Thoracic OncologyElsevier BV · United States | 2.79Q1 | 6.72 2.65 down from 2023 | 736 | 98% | $4,100 | ||
10Critical CareOABioMed Central · United Kingdom | 2.66Q1 | 8.46 0.15 up from 2023 | 1,294 | 100% | $4,190 | ||
11European Urology OncologyElsevier BV · Netherlands | 2.49Q1 | 6.73 1.19 down from 2023 | 314 | 60% | $3,790 | ||
12American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 2.46Q1 | 7.16 0.41 up from 2023 | 1,511 | 80% | — | ||
13Modern PathologyElsevier BV · United States | 2.39Q1 | 5.87 1.74 down from 2023 | 605 | 98% | $4,480 | ||
14Medical SciencesOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.24Q1 | 5.49 0.56 down from 2023 | 215 | 100% | $1,689 | ||
15Gastric CancerSpringer Science+Business Media · Japan | 2.17Q1 | 6.49 0.09 up from 2023 | 281 | 98% | $3,590 | ||
16The Journal of UrologyLippincott Williams & Wilkins · United States | 2.11Q1 | 4.42 0.72 down from 2023 | 418 | 3% | $3,000 | ||
17Clinical eHealthOAElsevier BV · China | 1.94Q1 | 7.12 0.48 down from 2023 | 50 | 100% | $995 | ||
18Annals of Intensive CareOASpringer Nature · France | 1.94Q1 | 6.00 0.36 down from 2023 | 417 | 100% | $3,490 | ||
19ThoraxBMJ · United Kingdom | 1.87Q1 | 5.64 0.66 down from 2023 | 611 | 50% | — | ||
20Seminars in PerinatologyElsevier BV · United States | 1.79Q1 | 3.10 0.80 down from 2023 | 227 | 40% | $4,370 | ||
21Respiratory ResearchOABioMed Central · United Kingdom | 1.78Q1 | 5.40 0.07 up from 2023 | 982 | 100% | $3,490 | ||
22Journal of Translational Internal MedicineDe Gruyter · Poland | 1.74Q1 | 6.21 2.59 up from 2023 | 164 | 100% | $1,130 | ||
23Clinics in Chest MedicineElsevier BV · United States | 1.69Q1 | 4.43 1.15 up from 2023 | 213 | 20% | $3,350 | ||
24Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 1.63Q1 | 4.09 0.33 down from 2023 | 273 | 18% | — | ||
25Radiotherapy and OncologyElsevier BV · Netherlands | 1.63Q1 | 4.61 0.10 down from 2023 | 1,155 | 15% | $3,770 | ||
26Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 1.61Q1 | 3.11 0.54 down from 2023 | 171 | 37% | $4,590 | ||
27Targeted OncologyAdis, Springer Healthcare · France | 1.58Q1 | 4.15 0.80 down from 2023 | 206 | 61% | $4,990 | ||
28npj Primary Care Respiratory MedicineOANature Portfolio · United Kingdom | 1.52Q1 | 5.80 2.06 up from 2023 | 141 | 100% | $3,390 | ||
29Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 1.52Q1 | 2.93 1.38 down from 2023 | 124 | 6% | — | ||
30Canine Medicine and GeneticsOABioMed Central · United Kingdom | 1.51Q1 | 3.38 1.71 down from 2023 | 33 | 100% | $1,990 | ||
31European Urology FocusElsevier BV · Netherlands | 1.51Q1 | 4.52 0.32 up from 2023 | 539 | 31% | $3,800 | ||
32PathologicaOAPacini Editore · Italy | 1.45Q1 | 3.21 0.28 down from 2023 | 155 | 100% | — | ||
33Cancer ImagingOABioMed Central · United Kingdom | 1.44Q1 | 3.99 0.05 up from 2023 | 265 | 100% | $2,790 | ||
| 1.43Q1 | 3.97no 2023 value | 32 | 100% | $1,100 | — | ||
35JCO Precision OncologyLippincott Williams & Wilkins · United States | 1.43Q1 | 4.53 0.38 down from 2023 | 603 | 63% | — | ||
36Advances in TherapyAdis, Springer Healthcare · United Kingdom | 1.40Q1 | 4.39 0.38 up from 2023 | 1,032 | 82% | $4,790 | ||
37Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.39Q1 | 5.03 0.27 up from 2023 | 428 | 53% | $5,190 | ||
38European journal of medical researchOABioMed Central · United Kingdom | 1.39Q1 | 4.07 0.51 up from 2023 | 1,062 | 100% | $3,190 | ||
39European Urology Open ScienceOAElsevier BV · Netherlands | 1.37Q1 | 4.22 1.22 up from 2023 | 499 | 100% | $1,800 | ||
40Archives of Disease in Childhood Fetal & NeonatalBMJ · United Kingdom | 1.37Q1 | 3.37 0.14 up from 2023 | 382 | 54% | — | ||
41LungSpringer Science+Business Media · Germany | 1.35Q1 | 3.98 1.18 down from 2023 | 241 | 56% | $4,290 | ||
42Seminars in Vascular SurgeryElsevier BV · United States | 1.33Q1 | 2.80 1.14 down from 2023 | 157 | 37% | $3,760 | ||
43Lung CancerElsevier BV · Netherlands | 1.33Q1 | 4.51 0.09 up from 2023 | 729 | 25% | $3,390 | ||
44Therapeutic Advances in UrologyOASAGE Publishing · United Kingdom | 1.33Q1 | 4.09 1.12 up from 2023 | 143 | 100% | $2,650 | ||
45British Journal of UrologyWiley · United Kingdom | 1.32Q1 | 3.33 0.09 down from 2023 | 659 | 61% | $4,770 | ||
46Seminars in Respiratory and Critical Care MedicineThieme Medical Publishers (Germany) · United States | 1.32Q1 | 3.44 0.84 up from 2023 | 213 | 19% | — | ||
47BMJ Open Respiratory ResearchOABMJ · United Kingdom | 1.32Q1 | 3.92 0.40 down from 2023 | 417 | 100% | $2,085 | ||
48CHEST JournalElsevier BV · United States | 1.32Q1 | 3.25 0.33 down from 2023 | 2,052 | 57% | $4,160 | ||
49Annals of the American Thoracic SocietyAmerican Thoracic Society · United States | 1.30Q1 | 3.17 0.94 down from 2023 | 849 | 67% | — | ||
50Frontiers in MedicineOAFrontiers Media · Switzerland | 1.29Q1 | 3.69 0.18 down from 2023 | 9,328 | 100% | $3,801 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
80 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 364
- Window papers (baseline)
- 218,995 +15.5% from indicator year 2021
- Median OJR
- 0.64 -3.5% from indicator year 2021
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.